ARCHIVES

ODAC Recommends Femara Campath For FDA Approval.

This article is from The Cancer Letter archive.

Vol. 27 No. 01 | January 5, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Develops Plan For Specialized Centers, But Funding $67.5M Program Depends On New $$

July 5, 1991

Cancer Panel Urges Improved Funding For Basic Science

June 16, 1995

(8-page issue)

November 2, 2002

In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse

June 6, 1997

Surgeon General plans new report, database, on tobacco.

January 16, 2004

GAO Criticizes Eppley, NCI For ‘Deficiencies’ In Review, Monitoring, Management of Contract

February 24, 1978